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Introduction Previous studies have suggested that iron deficiency anaemia (IDA) is an indicator 
of poor prognosis in colorectal cancer (CRC), but this may be due to confounding – IDA is much 
commoner in right-sided CRC, which tends to late presentation and therefore a worse 
prognosis. This study aims to determine the effect of diagnosing CRC through the detection of 
IDA on tumour stage - a surrogate marker of prognosis in CRC - whilst controlling for tumour 
side. 
 
Methods A total of 1154 cases of CRC with adequate clinical information were identified from 
the MDT records of a single general hospital for 2010–2016. Histological confirmation of 
adenocarcinoma was available in 90%. Each case was staged on the basis of the available 
radiological and surgical evidence, and the route of presentation identified. Because tumour 
side and presentation are surrogate markers of prognosis in CRC, these variables were merged 
to create a new variable to reflect CRC prognosis, and analysed using binary logistic regression 
models. 
 
Results A summary of the basic patient data is shown in table 1. As anticipated, most cases 
presenting with IDA proved to have right-sided tumours, whilst the majority of cases diagnosed 
through screening were left-sided.  
 
Table 1 
 IDA Screening Symptomatic Overall 
Number 171 213 770 1154 
Sex ratio – M/F 1.1 1.5 1.3 1.3 
Age (years) – mean (sd) 77 (± 11) 68 (± 6) 73 (± 13) 72 (± 12) 
Hb (g/l) – mean (sd) 88 (± 17) 133 (± 19) 122 (± 23) 119 (± 25) 
Early stage (I or II) – n (%) 89 (52.0%) 127 (59.6%) 304 (39.5%) 520 (45.1%) 
Right-sided – n (%) 141 (82.5%) 71 (33.3%) 243 (31.6%) 455 (39.4%) 
 
As expected, left-sided tumours diagnosed through screening (mostly in the national bowel 
cancer screening programme) were significantly down-staged in comparison to those 
presenting with symptomatic disease – with an odds ratio for early stage disease of 2.09 (95% 
CI 1.4 - 3.1, P<0.001). 
The key finding in this study is that right-sided tumours diagnosed following the detection of 
IDA also appear to be down-staged compared to those presenting with symptomatic disease – 
with an odds ratio for early stage disease of 2.52 (95% CI 1.6 - 3.8, P<0.0001). 
 
Conclusion The findings suggest a prognostic benefit to diagnosing right-sided CRC through the 
detection of IDA, with a benefit comparable to that of the screening programme for left-sided 
CRC. This strengthens the case for a systematic approach to blood count monitoring in the 
population at-risk of CRC. 
 
